370 related articles for article (PubMed ID: 35287713)
1. Calorie restriction improves metabolic state independently of gut microbiome composition: a randomized dietary intervention trial.
Sowah SA; Milanese A; Schübel R; Wirbel J; Kartal E; Johnson TS; Hirche F; Grafetstätter M; Nonnenmacher T; Kirsten R; López-Nogueroles M; Lahoz A; Schwarz KV; Okun JG; Ulrich CM; Nattenmüller J; von Eckardstein A; Müller D; Stangl GI; Kaaks R; Kühn T; Zeller G
Genome Med; 2022 Mar; 14(1):30. PubMed ID: 35287713
[TBL] [Abstract][Full Text] [Related]
2. Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial.
Schübel R; Nattenmüller J; Sookthai D; Nonnenmacher T; Graf ME; Riedl L; Schlett CL; von Stackelberg O; Johnson T; Nabers D; Kirsten R; Kratz M; Kauczor HU; Ulrich CM; Kaaks R; Kühn T
Am J Clin Nutr; 2018 Nov; 108(5):933-945. PubMed ID: 30475957
[TBL] [Abstract][Full Text] [Related]
3. The effects of intermittent calorie restriction on metabolic health: Rationale and study design of the HELENA Trial.
Schübel R; Graf ME; Nattenmüller J; Nabers D; Sookthai D; Gruner LF; Johnson T; Schlett CL; von Stackelberg O; Kirsten R; Habermann N; Kratz M; Kauczor HU; Ulrich CM; Kaaks R; Kühn T
Contemp Clin Trials; 2016 Nov; 51():28-33. PubMed ID: 27687742
[TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women.
Alemán JO; Bokulich NA; Swann JR; Walker JM; De Rosa JC; Battaglia T; Costabile A; Pechlivanis A; Liang Y; Breslow JL; Blaser MJ; Holt PR
J Transl Med; 2018 Sep; 16(1):244. PubMed ID: 30176893
[TBL] [Abstract][Full Text] [Related]
5. Effect of intermittent versus continuous calorie restriction on body weight and cardiometabolic risk markers in subjects with overweight or obesity and mild-to-moderate hypertriglyceridemia: a randomized trial.
Maroofi M; Nasrollahzadeh J
Lipids Health Dis; 2020 Oct; 19(1):216. PubMed ID: 33028352
[TBL] [Abstract][Full Text] [Related]
6. Adherence and Dietary Composition during Intermittent vs. Continuous Calorie Restriction: Follow-Up Data from a Randomized Controlled Trial in Adults with Overweight or Obesity.
Pannen ST; Maldonado SG; Nonnenmacher T; Sowah SA; Gruner LF; Watzinger C; Nischwitz K; Ulrich CM; Kaaks R; Schübel R; Grafetstätter M; Kühn T
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916366
[TBL] [Abstract][Full Text] [Related]
7. Effects of a chronotype-adapted diet on weight loss, cardiometabolic health, and gut microbiota: study protocol for a randomized controlled trial.
Dinu M; Lotti S; Pagliai G; Napoletano A; Asensi MT; Giangrandi I; Marcucci R; Amedei A; Colombini B; Sofi F
Trials; 2024 Feb; 25(1):152. PubMed ID: 38419068
[TBL] [Abstract][Full Text] [Related]
8. A High Protein Calorie Restriction Diet Alters the Gut Microbiome in Obesity.
Dong TS; Luu K; Lagishetty V; Sedighian F; Woo SL; Dreskin BW; Katzka W; Chang C; Zhou Y; Arias-Jayo N; Yang J; Ahdoot A; Li Z; Pisegna JR; Jacobs JP
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33096810
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota predicts body fat change following a low-energy diet: a PREVIEW intervention study.
Jian C; Silvestre MP; Middleton D; Korpela K; Jalo E; Broderick D; de Vos WM; Fogelholm M; Taylor MW; Raben A; Poppitt S; Salonen A
Genome Med; 2022 May; 14(1):54. PubMed ID: 35599315
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome remodeling and metabolomic profile improves in response to protein pacing with intermittent fasting versus continuous caloric restriction.
Mohr AE; Sweazea KL; Bowes DA; Jasbi P; Whisner CM; Sears DD; Krajmalnik-Brown R; Jin Y; Gu H; Klein-Seetharaman J; Arciero KM; Gumpricht E; Arciero PJ
Nat Commun; 2024 May; 15(1):4155. PubMed ID: 38806467
[TBL] [Abstract][Full Text] [Related]
11. Effects of gut microbiota and fatty acid metabolism on dyslipidemia following weight-loss diets in women: Results from a randomized controlled trial.
Ma Y; Sun Y; Sun L; Liu X; Zeng R; Lin X; Li Y
Clin Nutr; 2021 Nov; 40(11):5511-5520. PubMed ID: 34656033
[TBL] [Abstract][Full Text] [Related]
12. Design of the Building Research in CRC prevention (BRIDGE-CRC) trial: a 6-month, parallel group Mediterranean diet and weight loss randomized controlled lifestyle intervention targeting the bile acid-gut microbiome axis to reduce colorectal cancer risk among African American/Black adults with obesity.
McLeod A; Wolf P; Chapkin RS; Davidson LA; Ivanov I; Berbaum M; Williams LR; Gaskins HR; Ridlon J; Sanchez-Flack J; Blumstein L; Schiffer L; Hamm A; Cares K; Antonic M; Bernabe BP; Fitzgibbon M; Tussing-Humphreys L
Trials; 2023 Feb; 24(1):113. PubMed ID: 36793105
[TBL] [Abstract][Full Text] [Related]
13. The Potential Roles of Very Low Calorie, Very Low Calorie Ketogenic Diets and Very Low Carbohydrate Diets on the Gut Microbiota Composition.
Rondanelli M; Gasparri C; Peroni G; Faliva MA; Naso M; Perna S; Bazire P; Sajuox I; Maugeri R; Rigon C
Front Endocrinol (Lausanne); 2021; 12():662591. PubMed ID: 34054731
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the low-calorie DASH diet and a low-calorie diet on serum TMAO concentrations and gut microbiota composition of adults with overweight/obesity: a randomized control trial.
Diao Z; Molludi J; Latef Fateh H; Moradi S
Int J Food Sci Nutr; 2024 Mar; 75(2):207-220. PubMed ID: 38149315
[TBL] [Abstract][Full Text] [Related]
15. Changes in Plasma Short-Chain Fatty Acid Levels after Dietary Weight Loss Among Overweight and Obese Adults over 50 Weeks.
Sowah SA; Hirche F; Milanese A; Johnson TS; Grafetstätter M; Schübel R; Kirsten R; Ulrich CM; Kaaks R; Zeller G; Kühn T; Stangl GI
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32053988
[TBL] [Abstract][Full Text] [Related]
16. Link between gut microbiota and health outcomes in inulin -treated obese patients: Lessons from the Food4Gut multicenter randomized placebo-controlled trial.
Hiel S; Gianfrancesco MA; Rodriguez J; Portheault D; Leyrolle Q; Bindels LB; Gomes da Silveira Cauduro C; Mulders MDGH; Zamariola G; Azzi AS; Kalala G; Pachikian BD; Amadieu C; Neyrinck AM; Loumaye A; Cani PD; Lanthier N; Trefois P; Klein O; Luminet O; Bindelle J; Paquot N; Cnop M; Thissen JP; Delzenne NM
Clin Nutr; 2020 Dec; 39(12):3618-3628. PubMed ID: 32340903
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota modulation with long-chain corn bran arabinoxylan in adults with overweight and obesity is linked to an individualized temporal increase in fecal propionate.
Nguyen NK; Deehan EC; Zhang Z; Jin M; Baskota N; Perez-Muñoz ME; Cole J; Tuncil YE; Seethaler B; Wang T; Laville M; Delzenne NM; Bischoff SC; Hamaker BR; Martínez I; Knights D; Bakal JA; Prado CM; Walter J
Microbiome; 2020 Aug; 8(1):118. PubMed ID: 32814582
[TBL] [Abstract][Full Text] [Related]
18. Comparison of weight loss induced by daily caloric restriction versus intermittent fasting (DRIFT) in individuals with obesity: study protocol for a 52-week randomized clinical trial.
Ostendorf DM; Caldwell AE; Zaman A; Pan Z; Bing K; Wayland LT; Creasy SA; Bessesen DH; MacLean P; Melanson EL; Catenacci VA
Trials; 2022 Aug; 23(1):718. PubMed ID: 36038881
[TBL] [Abstract][Full Text] [Related]
19. Arabinoxylan oligosaccharides and polyunsaturated fatty acid effects on gut microbiota and metabolic markers in overweight individuals with signs of metabolic syndrome: A randomized cross-over trial.
Kjølbæk L; Benítez-Páez A; Gómez Del Pulgar EM; Brahe LK; Liebisch G; Matysik S; Rampelli S; Vermeiren J; Brigidi P; Larsen LH; Astrup A; Sanz Y
Clin Nutr; 2020 Jan; 39(1):67-79. PubMed ID: 30827722
[TBL] [Abstract][Full Text] [Related]
20. The Gut Microbiota during a Behavioral Weight Loss Intervention.
Stanislawski MA; Frank DN; Borengasser SJ; Ostendorf DM; Ir D; Jambal P; Bing K; Wayland L; Siebert JC; Bessesen DH; MacLean PS; Melanson EL; Catenacci VA
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
